Washington – A seminar series starting Tuesday will address current practices for acute inhalation toxicity testing and examine the development and implementation of alternative approaches to reduce and replace acute inhalation testing in mammals for both global regulatory agencies and non-regulatory purposes.
The six-part series is co-hosted by the PETA International Science Consortium Ltd. and the U.S. NTP Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM). The monthly webinars begin on March 29 and end in August 2016. They are open to the public and free of charge. Interested individuals will need to register only once to view the entire series. Details and registration information are available here.
Dr. Jon Hotchkiss, The Dow Chemical Company, and Mr. Ian Indans, Health and Safety Executive, UK, will discuss regulatory requirements and non-regulatory testing in the first webinar on Tuesday, March 29.
On Tuesday, April 26, Dr. Marianna Gaca, British American Tobacco, and Dr. Annie Jarabek, U.S. Environmental Protection Agency, Office of Research and Development, will discuss state-of-the-science, practical application, and dosimetry considerations for in vitro and ex vivo methods. On Thursday, May 26, Dr. Grace Patlewicz, U.S. Environmental Protection Agency, and Dr. Dan Wilson, The Dow Chemical Company, will discuss practical application of in silico methods.
About the PETA International Science Consortium Ltd.: The PETA International Science Consortium was established in 2012 to coordinate the scientific and regulatory expertise of its members – PETA UK, PETA US, PETA France, PETA Germany, PETA India, PETA Netherlands, PETA Asia, and PETA Australia. The Science Consortium works to accelerate and fund the development, validation, and global implementation of alternatives to testing on animals.